Tue.Jul 25, 2023

article thumbnail

Biogen, working through a 'transition,' plots 1,000 more layoffs by 2025

Fierce Pharma

In reporting its first-quarter earnings, Biogen said it would halt the development of at least four investigational drugs to allow the company to focus on more lucrative opportunities. | In a sizable cost-cutting measure, Biogen will lay off 1,000 employees by 2025, it announced in presenting its second quarter earnings. With the company starting 2023 with 8,725 employees, that’s an 11.5% reduction of the workforce.

230
230
article thumbnail

B2B Sales: How To Get Results In 2023

Spotio

B2B sales has evolved over the years. Cold calling and direct mail are still useful for some sales processes, but the way in which we do business has changed a lot. More companies are investing in B2B sales teams — inside and outside — across a range of industries. The B2B buying process now has more decision-makers and touchpoints than it did just a few years ago.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA clears Tarsus' Xdemvy as first treatment for common eyelid disease

Fierce Pharma

Patients with the eyelid disease Demodex blepharitis can now see a cure in Tarsus Pharmaceuticals’ Xdemvy, the first FDA-approved treatment for an ailment that affects some 25 million Americans.

FDA 223
article thumbnail

How to Find the Best Digital Marketing Agency for Your Business 

Pharma Marketing Network

In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Bayer expects gloomier 2023 as lower glyphosate sales bolster breakup advocates' case

Fierce Pharma

Just as the calls for a business separation grow louder at Bayer, the company’s weedkiller performance is bolstering the argument with dramatically declining sales. | Just as the calls for a business separation grow louder at Bayer, the company’s weedkiller performance is bolstering the argument with dramatically declining sales.

Sales 220
article thumbnail

How to Customize Your Audience in Ads Manager for the Pharma Industry 

Pharma Marketing Network

Ads Manager is a powerful platform that can help pharma companies reach their target audience and achieve their marketing goals. One of the ways to do this is to customize your audience. This means targeting your ads to people who are most likely to be interested in your products or services. Here are some tips for customizing your audience in Ads Manager for the pharma industry: Use demographics: You can target your ads based on demographics, such as age, gender, location, and interests.

More Trending

article thumbnail

Rigorous Data Are Key to Convince Payers, Investors in the World of Digital Therapeutics

MedCity News

Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers.

FDA 97
article thumbnail

FibroGen CEO Conterno, who scrapped post-Lilly plans over roxadustat hype, resigns after launch setbacks

Fierce Pharma

Hopes around FibroGen’s anemia drug roxadustat were high in early 2020 when Enrique Conterno arrived as the company’s new CEO. | Enrique Conterno has resigned from the FibroGen CEO post for “personal reasons,” the company said Tuesday. As FibroGen looks for a permanent successor, the company’s chief commercial officier Thane Wettig will don the mantle of interim chief executive officer.

article thumbnail

Novel antibody therapeutic demonstrates potential in GVHD

European Pharmaceutical Review

Axatilimab, an anti-CSF-1R antibody to treat chronic graft-versus-host disease (GVHD) has, in a pivotal Phase II trial, demonstrated overall response rates (ORR) of 74 percent, 67 percent and 50 percent, within the first six months of treatment. “[It] is the first investigational chronic GVHD treatment to target inflammation and fibrosis through the inhibition of disease associated macrophages,” stated Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals.

article thumbnail

How to Increase SEO on Google Ads for the Pharma Industry

Pharma Marketing Network

Google Ads is a great way to reach a wider audience for your pharma business. However, if you want to get the most out of your Google Ads campaigns, you need to optimize them for SEO. Here are some tips on how to increase SEO on Google Ads for the pharma industry: Use relevant keywords: When you’re creating your Google Ads campaigns, make sure to use relevant keywords.

Pharma 97
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Altro Pharmaceuticals, LSPedia Team Up on DSCSA Compliance

Pharmaceutical Commerce

With FDA’s compliance deadline only three months away, the tech-supply chain partnership is expected to help manufacturers and wholesalers meet the Nov. 27 deadline.

article thumbnail

How to Go Beyond Demographics for Effective Marketing to Consumers in the Pharma Industry 

Pharma Marketing Network

Traditionally, pharmaceutical companies have relied on demographics to target their marketing efforts. This means that they have focused on reaching consumers based on factors such as age, gender, income, and location. While demographics can be a useful starting point, they are not always enough to create effective marketing campaigns. This is because consumers are not just defined by their demographics.

article thumbnail

Hospitals’ Price Transparency Compliance Is Improving Despite Remaining Low at 36%

MedCity News

About 36% of U.S. hospitals are in compliance with CMS’ price transparency rule, up from 24.5% in February, according to a new report. This progress will remain slow unless CMS can do a better job of effectively enforcing its rule, the report declared.

article thumbnail

Smart Pants Track Physical Activity

Medgadget

Engineers at the Federal University of Espirito Santo in Brazil have developed smart pants that can non-intrusively track physical movements and provide updates to caregivers if the people they’re taking care of are showing signs of distress. This application could be very useful for people who are monitoring elderly patients in healthcare facilities.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

The Biden Administration Proposes Rule To Improve Mental Health Parity

MedCity News

A new proposed rule by the Biden-Harris Administration would require health plans to improve their analyses of their mental health benefits and make clear that they cannot engage in practices that make it more difficult for members to access mental health support compared to physical health.

91
article thumbnail

Boehringer, Lilly secure EC approval for Jardiance to treat adults with CKD

Pharmaceutical Technology

Boehringer Ingelheim and Eli Lilly have secured approval from the EC for Jardiance to treat adults with chronic kidney disease (CKD).

98
article thumbnail

A Personalized Approach to Medication Nonadherence [Sponsored]

MedCity News

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

Medical 88
article thumbnail

Soft Coating Cools Wearable Devices

Medgadget

Scientists at the City University of Hong Kong have developed a coating for wearable technologies that can help to dissipate heat, reducing the chances of skin burns and increasing the life of such devices. Electronic devices can generate heat, but this can be problematic for wearables that are in constant contact with the skin. The heat may be uncomfortable, may overheat the device itself, and could even cause skin burns.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Astellas Strikes Another Deal to Expand in Cancer, Partnering With PeptiDream

MedCity News

Astellas Pharma has identified targeted protein degradation as one of the key areas for growth. The PeptiDream alliance is the latest one Astellas has struck in this particular area of drug research as it aims to find new ways to go after difficult cancer targets.

Pharma 85
article thumbnail

Small molecule API market to value $284.7 billion by 2032

European Pharmaceutical Review

A report from Market Research Biz has illustrated that the small molecule active pharmaceutical ingredient (API) market is expected value around $284.7 billion by 2032. This is a rise from $162.8 billion in 2022. A compound annual growth rate (CAGR) growth of 5.9 percent during the forecast period from 2023 to 2032 is predicted. The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses

article thumbnail

UpLift Secures $10.7M To Expand Access to Behavioral Health Services

MedCity News

UpLift’s Series A funding round was led by Ballast Point Ventures and included participation from Kapor Capital, Front Porch Ventures and B Capital. In total, UpLift has raised more than $22 million.

74
article thumbnail

AstraZeneca links up with Qureight on lung disease research

PharmaTimes

The company will utilise Qureight’s AI technology to undergo studies across a variety of complex lung diseases - News - PharmaTimes

82
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Photonic Radar Monitors Breathing from a Distance

Medgadget

Engineers at the University of Sydney have developed a photonic radar that allows them to monitor breathing rates without the need to attach equipment to a patient’s skin. Wired or more invasive systems may not be suitable for everyone – for instance, burn patients with damaged skin or infants with a tiny body surface area may not be able to avail of such systems.

article thumbnail

Patient Assistance Programs Pharmacy Options

Pharmaceutical Commerce

Choosing the right pharmacy to administer the program involves a number of factors.

article thumbnail

Crescendo widens pivotal solid tumour therapy trial

PharmaTimes

The CB307 study expansion involves the addition of a new pembrolizumab combination cohort - News - PharmaTimes

76
article thumbnail

The Ultimate Guide to Becoming a Successful Medical Device Sales Representative

Rep-Lite

The medical sales industry has experienced remarkable growth in recent years, with innovations and advancements driving healthcare to new heights. At the heart of this dynamic sector are the unsung heroes – the medical sales representatives. These skilled professionals play a pivotal role in bridging the gap between cutting-edge medical equipment and technologies and the healthcare providers who depend on them to save lives.

Medical 52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

All You Need To Know About Spine Med Sales With Taylor Laneville

Evolve Your Success

Working in the field of spine medical sales is not just a job, but an extraordinary expedition driven by purpose, resilience, and ingenuity. In today’s episode, we dive into the world of spine medical sales with Taylor Laneville. He is a dynamic individual who transitioned from being an organic chemist to a highly esteemed medical sales consultant.

Sales 52
article thumbnail

The potential of AI in healthcare Part II: opportunities and challenges for providers

Clarify Health

Historically, the healthcare field hasn’t exactly been at the forefront of adopting the latest technology — but things have gotten a lot better over the past decade. For example, healthcare stakeholders now widely acknowledge AI’s pivotal role in the industry. From enhancing disease diagnosis accuracy to enabling personalized treatment plans to automating administrative tasks, AI boasts a myriad of use cases for providers, payers, life sciences firms, pharmacies, and other healthca

article thumbnail

How Mock Sales Call Exercises Should Fit in Your Sales Training Program

Quantified

Cold calls are almost universally hated—in fact, 63% of salespeople call them the worst part of the job. Of course, sales reps have to do more than cold calling. There are follow-up calls, sales demos, calls for retaining relationships, and (especially for key accounts) calls for customer support. Calls remain one of the most important types of touchpoints for salespeople across virtually every industry, and reckoning with the negative feelings surrounding sales calls is one of the most importan

article thumbnail

How Sponsorship Can Amplify Healthcare Awareness and Education 

Pharma Marketing Network

Sponsorships are a powerful tool that businesses can use to amplify healthcare awareness and education. By partnering with healthcare organizations, businesses can reach a wider audience with important health information and help to promote healthy lifestyles. Here are some examples of how sponsorships can be used to amplify healthcare awareness and education: Johnson & Johnson sponsors the Healthy Living Index.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.